Search filters

List of works by Jean G MacFadyen

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

scientific article published on 29 March 2009

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

scientific article published on 27 August 2017

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial ⬇️

scientific article published on August 11, 2012

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

scientific article published on 25 August 2017

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

scientific article published on 23 July 2010

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

scientific article published on 01 October 2018

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prev

scientific article published on 22 September 2009

Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

scientific article published on 10 June 2010

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

scientific article published on 13 November 2017

Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial

scientific article published on 18 September 2018

Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial

scientific article published on 14 March 2012

Paulina is supported by:

About Paulina

Help